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Observational epidemiological studies have identified associations between a number of modifiable 
exposures and outcomes, including in dermatology, such as between smoking and psoriasis. 
However, it is challenging to determine if such relationships are causal, due to the potential of 
confounding and reverse causation. Mendelian Randomization (MR) is a statistical method which 
can be used to investigate the causal relationships between an exposure and outcome, by using a 
genetic instrument that proxies the exposure. The resulting estimate (under certain assumptions) 
can be interpreted as the causal estimate, free of confounding and reverse causation. In this review, 
we provide an overview of how to undertake an MR analysis, with examples from the dermatology 
literature. We also discuss the challenges and future directions of this method. 
Glossary 
Term Description 
Confounder A variable that is a common cause of both the exposure and the outcome 
Exposure 
An explanatory variable used to explain or predict an outcome variable, such as a trait or 
disease 
F statistic 
Obtained from the regression of a response variable upon a predictor variable, for example 
the regression of the exposure of interest upon an instrumental variable (IV). This can be 
used as a measure of the strength of association between an IV and the exposure, hence 
giving an indication of the strength of the instrument. The further away the F statistic is 
from 1, the stronger the instrument. The F statistic also depends on the size of the sample. 
GWAS 
Genome-wide association study. Involves analysing genetic variants across the genome, 







A variable that is associated with an exposure of interest, but not the outcome. In MR 
studies genetic variants are used as IVs. A valid IV must also be independent of 




A method for assessing the causal effect of an exposure upon an outcome, using genetic 
variants as instruments or "proxies" for the exposure variable. 
MR-base 
A centralized database of summary GWAS data, and an analytical platform to perform 
Mendelian Randomization and sensitivity analyses  
PheWAS 
Phenome-wide association study. Involves analysing the association between genetic 
variants and multiple phenotypic variables (on a phenome-wide scale) rather than a single 
phenotype.  
Pleiotropy 
Occurs when a genetic instrument is independently associated with multiple risk factors 
for the outcome, in addition to the exposure of interest. This results in the third IV 
assumption being violated that assumes that the genetic instrument only affects the 
outcome via the exposure. 
Reverse 
causality 
Where an association is due to the assumed outcome variable influencing the exposure 
variable, rather than the exposure influencing the outcome 
Sensitivity 
Analysis 






Observational epidemiological studies have uncovered relationships between disease and various 
explanatory factors known as exposures. Notable examples in dermatology include the association of 
psoriasis with smoking (Armstrong et al. 2014), and more recently the association of atopic dermatitis 
(AD) with cardiovascular traits (Standl et al. 2017). However, traditional observational studies are 
prone to biases such as confounding, where the observed association may be due to the exposure 
being related to other lifestyle or socioeconomic factors that have a casual influence on disease. 
Furthermore, observed associations may be due to reverse causation, where disease is actually 
influencing the assumed exposure (Lawlor et al. 2008), for example having psoriasis could influence 
an individual’s propensity to smoke. Mendelian Randomization (MR) presents as a method to evaluate 
causality in an observational study setting. We aim to provide an overview of the principle of MR and 
the statistical methods used. 
 
The principle of MR 
MR is a form of instrumental variable (IV) analysis where genetic variants are used as instruments (or 
proxies) for an exposure of interest. As genetic variants are randomly segregated at conception and 
cannot be influenced by confounding factors or the outcome itself, they can be used to estimate the 
causal effect of the exposure upon an outcome (Lawlor et al. 2008) (Figure 1).  
Performing MR requires two pieces of information. (1) the effect of the genetic instrument on the 
exposure (𝛽𝑋𝑍), and (2) the effect of the genetic instrument on the outcome (𝛽𝑌𝑍). These can then be 
used to estimate the causal effect of the exposure on the outcome (𝐶𝑎𝑢𝑠𝑎𝑙 𝛽𝑌𝑋) using the following 
ratio (Wald 1940): 








For a genetic variant to qualify as an IV, three core assumptions must be satisfied. The variants (1) 
must be truly associated with the exposure of interest; (2) must not be associated with confounders 
of the exposure-outcome relationship; and (3) must only affect the outcome via the exposure and not 
through an alternative pathway (Zheng et al. 2017). The use of genetic variants in an MR framework 
can be compared to an RCT, where genotypes are used to randomise individuals to different 
subgroups (Lawlor et al. 2008). The effect of the genetic instrument on the outcome (𝛽𝑌𝑍) is analogous 
to an intention-to-treat effect from an association between randomisation and an outcome in an RCT 
(Burgess and Thompson 2015).  
 
 
Figure 1- Illustrative diagram of standard Mendelian Randomization (MR) analysis. A valid genetic instrument (Z) must be 
truly associated with the exposure (X), must not be associated with confounders (C), and should only have an effect on the 
outcome (Y) via the exposure. Dashed arrows represent violations of these MR assumptions. 
 
As MR requires estimates of the associations between genetic variants and the exposure and genetic 
variants and the outcome, the rise of genome-wide association studies (GWAS) (Tsoi et al. 2018) 
provide a wealthy resource of genetic instruments for MR. Published summary GWAS data can be 
obtained from various sources such as the GWAS catalogue (www.ebi.ac.uk/gwas/), MR-base 
(www.mrbase.org), or direct from the authors of the GWAS (Figure 2). Commonly, independent SNPs 




value<5x10-8) are used as genetic instruments for the exposure (Zheng et al. 2017), but MR analyses 
can be conducted using just a single genetic variant, or even using all variants in the genome 
(appropriately weighted by their effect on the exposure). Published MR studies in dermatology include 
those investigating causal relationships between fatty acids and melanoma (Liyanage et al. 2018), 
vitamin D levels and AD risk (Manousaki et al. 2017) as well as skin-aging (Noordam et al. 2017), and 
most recently with BMI and psoriasis risk (Budu-Aggrey et al. 2019) which will be referred to 
throughout this review. 
 
MR approaches and statistical methods 
MR study designs 
A basic MR study design involves obtaining all information required from the same set of individuals, 
meaning the genetic, exposure and outcome data are all available from the same study. This is known 
as one-sample MR. Large population-based studies such as the UK Biobank provide ideal datasets for 
such analysis to be carried out. However, it may not always be possible to gather exposure and 
outcome measures from the same dataset. Two-sample MR is therefore more commonly adopted, 
where the effect of genetic variants on the exposure is obtained from one sample, and the effect of 
genetic variants on the outcome is obtained from another. This approach has been greatly facilitated 
by the increasing availability of summary GWAS data, as well as analytical platforms to perform two-






Figure 2- Workflow for performing two-sample MR analysis, adapted from Elife (Hemani G, Zheng J, Elsworth B, Wade KH, 




We recently investigated causality between BMI and psoriasis using both one-sample MR with 
individual-level data from the UK Biobank and Nord-Trøndelag Health Study (HUNT), and two-sample 
MR with published summary GWAS data. Consistent results were obtained from both analyses. The 
combined causal estimate suggested a 9% increase in the risk of psoriasis per 1 unit increase in BMI 
(Budu-Aggrey et al. 2019) (Figure 3). This finding supports previous reports of weight loss improving 
the prognosis of psoriasis (Maglio et al. 2017) and could suggest weight control as an intervention to 





Figure 3 - One-sample and two-sample MR estimates give evidence of increased psoriasis risk with 1 unit increase in BMI 
(kg/m2). Adapted from Public Library of Science: PLoS Medicine (Budu-Aggrey A, Brumpton B, Tyrrell J, Watkins S, Modalsli 
EH, Celis-Morales C, et al. Evidence of a causal relationship between body mass index and psoriasis: A mendelian 
randomization study. Lewis C, editor. PLOS Med. Public Library of Science; 2019;16(1):e1002739), © 2019. 
 
A bi-directional MR approach can also be adopted, which investigates causal effects in both directions. 
This requires suitable genetic instruments to be available for both traits. Such analysis can help 
uncover the direction of causality that explains the observational association. For example, when 
considering the relationship between BMI and psoriasis, we performed bi-directional MR and found 
evidence that the observational relationship is largely due to the causal effect of higher BMI on 
psoriasis risk, rather than a causal effect of psoriasis influencing BMI (Budu-Aggrey et al. 2019).  
 
MR statistical methods 
The simplest method to perform MR involves dividing the effect of the genetic instrument on the 
outcome by the effect of the genetic instrument on the exposure. This is commonly termed as the 
“ratio of coefficients method” or the “Wald ratio method” (as shown in Eq. 1) and can be performed 
with either summarized or individual-level data (Burgess et al. 2017). Two-stage methods can also be 
applied, such as two-stage least squares (2SLS), as used in the BMI and psoriasis paper (Budu-Aggrey 
et al. 2019). This method involves regressing the exposure upon the genetic instruments, then 




for the true standard error to be estimated. Additional MR methods have been previously discussed 
elsewhere (Burgess et al. 2015). 
 
Combining multiple variants 
Where multiple genetic instruments are available for an exposure, these can be combined into a 
genetic risk score (GRS) and used as a single instrument to perform MR (Zheng et al. 2017). 
Alternatively, an inverse-variance weighted (IVW) approach can be applied, whereby the ratio 
estimate from each independent genetic variant is combined using a fixed-effect meta-analysis model, 
where each variant is assumed to provide independent information, and the contribution of each 




One major potential problem with MR is when the genetic instrument affects the outcome through 
an alternative pathway that is distinct from the exposure of interest (termed pleiotropy), which 
violates the third assumption (as outlined above). Various sensitivity methods have been developed 
to detect and address pleiotropy including MR-Egger regression, weighted-median analysis the mode-
based estimate and the latent causal variable method. These methods have different assumptions, 
but aim to estimate the true causal effect in the presence of modest levels of pleiotropy (O’connor 
and Price; Zheng et al. 2017). 
Methods and approaches for MR analysis Description 





Performed with genetic instruments, exposure 
and outcome data that have been measured in 
the same sample population. 
Two-sample MR 
The effect of the genetic instruments on 
exposure is obtained from a different sample to 
the effect of the genetic instruments on the 
outcome. 
Bi-directional MR 
The causal relationship between two traits is 
investigated in both directions. This approach 
can be applied to one-sample or two-sample 
MR. 
Statistical methods  
Wald ratio method 
Performed with a single genetic instrument (or 
genetic risk score) by dividing the coefficient of 
the outcome-instrument association by the 
coefficient of the exposure-instrument 
association. 
Two-stage least squares (2SLS) regression 
Involves two regression stages where the 
exposure is regressed upon the genetic 
instruments. The outcome is then regressed 
upon the genetically predicted exposure values 
from the first-stage regression. 
Combining multiple variants  
Inverse-variance weighted (IVW) estimator 
Combination of ratio estimates from individual 




contribution of each instrument is the inverse 
of the variance of its effect on the outcome. 
Genetic risk score (GRS) 
Multiple genetic instruments for an exposure 
are combined into a genetic risk score. This can 
then be used as a single instrument to perform 
MR. 
Sensitivity analysis  
MR-Egger regression 
Sensitivity analysis to perform MR with multiple 
instruments. This can be used to detect 
pleiotropy and provide a causal estimate that is 
robust to pleiotropy. 
Weighted-median estimator 
Sensitivity analysis to perform MR with multiple 
instruments. Will provide consistent causal 
estimates when at least 50% of the information 
in the analysis come from valid genetic 
instruments. 
Mode-based estimator 
An MR sensitivity analysis which will provide a 
robust causal estimate in the presence of 
pleiotropy, if the most common pleiotropy 
value is zero across the genetic instruments. 
Latent causal variable analysis 
Distinguishes between genetic correlation and 
causation by mediating the genetic correlation 
between two traits with a latent causal variable 






Challenges and limitations of MR studies 
Although MR has proven to be a useful tool to estimate causality, there are instances where MR may 
be limited, or the IV assumptions may be violated. In some cases, there may be only weak genetic 
instruments available for the exposure of interest. Genetic instruments that explain very little of the 
variance in exposure can result in weak instrument bias, where the causal estimates can be biased 
towards the null in a two-sample MR setting and towards the observational estimate in a one-sample 
MR setting (Zheng et al. 2017). This highlights the need for GWAS to uncover associated variants and 
strong, reliable instruments to perform MR. The F-statistic from the regression of the exposure on the 
genetic instrument indicates the strength of the instrument. It is recommended to use genetic variants 
with an F-statistic>10 (Burgess et al. 2013; Lawlor et al. 2008). As the F-statistic is dependent on 
sample size, weak instrument bias can also be addressed by utilising larger sample sizes (Burgess and 
Thompson 2015). Additionally, combining individual variants into a GRS increases the instrument 
strength. The instrument for BMI in our psoriasis analysis had an F-statistic of 7091, indicating a strong 
instrument for BMI (Budu-Aggrey et al. 2019).  
Although it is assumed that a genetic instrument is independent of confounders, this cannot be tested 
for all potential confounders. However, it is sensible to test for association between the genetic 
instrument and any available measured potential confounders.   
 
Applications and future directions for MR 
MR is commonly performed to investigate the causality of established observational associations. 
However, a “hypothesis-free” approach can also be adopted to uncover novel causal relationships. 
This involves performing MR on a phenome-wide scale, known as MR-pheWAS where the effect of a 




where telomere length was found to increase the risk of several cancers, while reducing the risk of 
non-neoplastic diseases (Haycock et al. 2017).  
MR can also be applied to investigate the causal role of molecular traits such as gene expression, 
methylation and protein biomarkers upon disease. In doing so, genetic variants associated with 
expression (eQTLs), methylation (mQTLs) or plasma protein levels (pQTLs) are used as genetic 
instruments for the exposure and can provide insight into the causal pathways that underlie disease. 
This has been demonstrated for AD, where MR analysis with pQTLS gave evidence that IL1RL2 and 
IL18R1 are causal proteins for AD risk (Sun et al. 2017).  
Many MR studies are performed in cohorts with limited ethnic variation. As demonstrated by Ogawa 
et al, trans-ethnic MR studies can make the causal estimate more robust to confounding by population 
stratification and more generalisable to broader ethnic backgrounds (Ogawa et al. 2018).  
We also expect that MR methods will begin to be applied to outcomes of disease progression (as 
opposed to onset), to enable them to be more informative for treatment of patients (Paternoster et 
al. 2017). Such studies have begun to emerge in other disease areas, such as Parkinson’s disease 
(Simon et al. 2014), and could potentially uncover novel therapeutic targets or drug repurposing 
opportunities in dermatology. 
 
Conclusion 
MR has proven to be a robust statistical method to infer causal relationships in observational studies. 
In this review, we have presented strategies for performing MR, as well as the limitations and 
promising extensions of this method. As large GWAS summary statistics and open-access datasets 
become increasingly available, and additional methods continue to be developed, this will increase 




in turn will aid the understanding of underlying mechanisms of disease and inform disease prevention 
and treatment. 
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• Mendelian Randomization (MR) is a statistical method for investigating causality between 
exposure and outcome variables in observational epidemiology 
• Unlike traditional observational studies, MR uses genetic variants as instruments (or proxies) for 
the exposure, hence avoiding confounding and reverse causation 
• Application of such methods in the field of dermatology is a promising area of research 
• Future directions and developments will allow MR to be valuable tool for investigating causal 
pathways for disease, as well as providing insight into therapeutic interventions 
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Multiple choice questions 
1. Which of the following is a limitation of observational studies that can be addressed with 
MR?  
A. Publication bias 
B. Selection bias 
C. Confounding 
D. Inadequate sample size 
 
2. Which of the following is NOT an assumption for a valid MR instrument? 
A. The instrument must be truly associated with the exposure and the outcome 
B. The instrument must be truly associated with the exposure 
C. The instrument must not be associated with confounders of the exposure-outcome 
relationship 
D. The instrument must only affect the outcome via the exposure 
 
3. Which of the following can be used to uncover the direction of a causal relationship? 
A. Two-sample MR  
B. Observational analysis 
C. One-sample MR 
D. Bi-directional MR 
 
4. Which of the following can be used to address pleiotropy in MR 
A. Wald ratio method 
B. MR-Egger regression 
C. Inverse-variance weighted estimator 





5. Which of the following statements is FALSE 
A. MR can be performed in a hypothesis-free manner 
B. MR estimates represent the effect of long-term exposures 
C. Pleiotropic genetic instruments cannot be included in MR analyses 





Multiple choice questions 
1. Which of the following are limitations of observational studies that can be addressed with 
MR?  
o Publication bias 
o Selection bias 
• Confounding 
Explanation: Traditional observational studies are limited by confounding, reverse causation and 
measurement error. MR can be used to evaluate causality in observational studies while avoiding 
these limitations. 
o Inadequate sample size 
 
 
2. Which of the following is NOT an assumption for a valid MR instrument? 
• The instrument must be truly associated with the exposure and the outcome 
Explanation: A valid MR instrument must satisfy three core assumptions. The instrument must be 
truly associated with the exposure, must not be associated with confounders of the exposure-
outcome relationship, and must only affect the outcome via the exposure and not through an 
alternative pathway. 
o The instrument must be truly associated with the exposure 
o The instrument must not be associated with confounders of the exposure-outcome 
relationship 






3. Which of the following can be used to uncover the direction of a causal relationship? 
o Two-sample MR 
o Observational analysis 
o One-sample MR 
• Bi-directional MR 
Explanation: Bi-directional MR involves investigating the causal effect of an exposure upon an 
outcome, as well evaluating the effect in the reverse direction of the outcome upon the exposure. In 
doing so, the direction of the causal relationship can be determined 
 
 
4. Which of the following can be used to address pleiotropy in MR 
o Wald ratio method 
• MR-Egger regression 
Explanation: MR-Egger regression can be performed to detect the presence of pleiotropy and also 
obtain a causal estimate that is robust to pleiotropy  
o Inverse-variance weighted estimator 
o Two-stage least squares 
 
 
5. Which of the following statements are FALSE 
o MR can be performed in a hypothesis-free manner 
o MR estimates represent the effect of long-term exposures 




Explanation: MR can be performed on a phenome-wide scale to investigate the causal effect of a 
single exposure upon multiple outcomes with MR-pheWAS. MR estimates also represent the effect 
of long-term exposures rather than short-term interventions. In addition, MR can be extended to 
investigate the causal effect of molecular traits upon disease, where eQTLS, mQTLS or pQTLs are 
used as genetic instruments. Genetic instruments that are pleiotropic are not valid for MR analysis, 
however, MR methods have been developed to address pleiotropy, that allow for both unpleiotropic 
and pleiotropic variants to be included. These include MR-Egger regression, weighted-median 
analysis and the mode-based estimate. 
 
o MR can be used to investigate the causal role of molecular phenotypes 
 
